Moderna

Founded in 2010, Moderna, Inc. is a trailblazing biotechnology company based in Cambridge, Massachusetts. The company is renowned for its innovative mRNA technology, which is at the forefront of therapeutic and vaccine development. With a commitment to transforming how diseases are treated, Moderna focuses on creating a new generation of medicines to improve the health of people globally.

Moderna's mission is to deliver on the promise of mRNA science to create a new class of transformative medicines for patients. The company's pipeline includes a broad spectrum of development programs targeting a diverse range of conditions, from infectious diseases to rare genetic disorders and beyond. By harnessing the power of mRNA, Moderna aims to address unmet medical needs and bring breakthrough treatments to market.

With Stéphane Bancel at the helm as CEO, Moderna has grown rapidly and made significant strides in the biotechnology sector. Employing 7,000 dedicated professionals, the company is committed to pushing the boundaries of science and medicine. Moderna continues to lead the charge in mRNA research, driven by its vision of a healthier world.